| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Departments of 1 Dermatology and 2 Dental Medicine, the 3 Institute of Medical Physics and Biophysics, and the 4 Institute of Anatomy, University of Münster, Germany; the 5 Department of Cell Biology, University of Alabama at Birmingham; 6 Division of Orthopedic Surgery, University of Wisconsin at Madison; and the 7 Division of Electron Microscopy, Department of Ophthalmology, University of Erlangen-Nürnberg, Germany.
PURPOSE. To assess the distribution of transglutaminase (TGase) activity in ocular tissues and the target structures for cross-linking.
METHODS. Cryosections from human and cynomolgus monkey eyes were incubated with the biotinylated amine donor substrate cadaverine (biotC), which was subsequently visualized with streptavidin-peroxidase. Confocal laser scanning was used to colocalize biotC and fibrillin, a major component of elastic microfibrils and the zonular fibers in particular. Cryosections and isolated bovine zonules were treated with purified TGase 2 and biotC. The distribution of different TGases (1, 2, 3, and factor XIII) was confirmed immunohistochemically.
RESULTS. Virtually all ocular tissues showed TGase activity with a remarkable preponderance for the ciliary body, zonular fibers, and blood vessel walls. Confocal laser scanning revealed fibrillin-containing microfibrils as a major target for TGase activity, in particular the ciliary zonules. Corneal epithelium and basement membrane showed a TGase cross-linking pattern similar to skin. Treatment of cryosections and isolated bovine zonular fibers with purified TGase 2 led to additional incorporation of biotC into extracellular matrix, particularly zonular fibers. The immunohistochemically predominant TGase 2 was associated with epithelia and particularly with connective tissue fibers. TGase 1 was restricted to the corneal epithelium, whereas factor XIII was found to be associated only with blood vessels. TGase 3 was absent.
CONCLUSIONS. TGase 2 appears to be an important cross-linker and thus stabilizer of ocular connective tissue. In particular, the zonular fibers are a major target for TGase 2. This is of relevance in hereditary microfibrillopathies such as Marfan syndrome, which exhibits distinct ocular manifestations such as elongated bulbus, retinal detachment, and subluxation of the lens. Purified or recombinant TGase might be of therapeutic use in the future.
This article has been cited by other articles:
|
|
 |
|
  S.-A. Jung, H. K. Lee, J. S. Yoon, S.-J. Kim, C. Y. Kim, H. Song, K.-C. Hwang, J. B. Lee, and J. H. Lee Upregulation of TGF-{beta}-Induced Tissue Transglutaminase Expression by PI3K-Akt Pathway Activation in Human Subconjunctival Fibroblasts Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 1952 - 1958. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Ovodenko, A. Rostagno, T. A. Neubert, V. Shetty, S. Thomas, A. Yang, J. Liebmann, J. Ghiso, and R. Ritch Proteomic Analysis of Exfoliation Deposits Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1447 - 1457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Tong, Z. Chen, C. S. De Paiva, R. Beuerman, D.-Q. Li, and S. C. Pflugfelder Transglutaminase Participates in UVB-Induced Cell Death Pathways in Human Corneal Epithelial Cells. Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4295 - 4301. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P N Robinson, E Arteaga-Solis, C Baldock, G Collod-Beroud, P Booms, A De Paepe, H C Dietz, G Guo, P A Handford, D P Judge, et al. The molecular genetics of Marfan syndrome and related disorders J. Med. Genet., October 1, 2006; 43(10): 769 - 787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Priglinger, C. S. Alge, D. Kook, M. Thiel, R. Schumann, K. Eibl, A. Yu, A. S. Neubauer, A. Kampik, and U. Welge-Lussen Potential role of tissue transglutaminase in glaucoma filtering surgery. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3835 - 3845. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zenkel, E. Poschl, K. von der Mark, C. Hofmann-Rummelt, G. O. H. Naumann, F. E. Kruse, and U. Schlotzer-Schrehardt Differential Gene Expression in Pseudoexfoliation Syndrome Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3742 - 3752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Adhikary, J. F. Crish, F. Bone, R. Gopalakrishnan, J. Lass, and R. L. Eckert An Involucrin Promoter AP1 Transcription Factor Binding Site Is Required for Expression of Involucrin in the Corneal Epithelium In Vivo Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1219 - 1227. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Adhikary, J. Crish, J. Lass, and R. L. Eckert Regulation of Involucrin Expression in Normal Human Corneal Epithelial Cells: A Role for Activator Protein One Invest. Ophthalmol. Vis. Sci., April 1, 2004; 45(4): 1080 - 1087. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X H Wan, E H Lee, H J Koh, J Song, E K Kim, C Y Kim, J B Lee, S-Y Kim, K Yao, and J H Lee Enhanced expression of transglutaminase 2 in anterior polar cataracts and its induction by TGF-{beta} in vitro Br. J. Ophthalmol., November 1, 2002; 86(11): 1293 - 1298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Sultan, C. Baudouin, O. Auzerie, M. De Saint Jean, M. Goldschild, and P.-J. Pisella Cornea in Marfan Disease: Orbscan and In Vivo Confocal Microscopy Analysis Invest. Ophthalmol. Vis. Sci., June 1, 2002; 43(6): 1757 - 1764. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nakamura, K. Nishida, A. Dota, M. Matsuki, K. Yamanishi, and S. Kinoshita Elevated Expression of Transglutaminase 1 and Keratinization-Related Proteins in Conjunctiva in Severe Ocular Surface Disease Invest. Ophthalmol. Vis. Sci., March 1, 2001; 42(3): 549 - 556. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
